From January 1, 2024 to April 1, 2024, the company has repurchased 6,500,000 shares, representing 0.46% for CNY 39.94 million. With this, the company has completed the repurchase of 15,500,000 shares, representing 1.11% for CNY 100.01 million under the buyback announced on December 8, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.08 CNY | -1.94% | +0.85% | +6.79% |
04-29 | Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-26 | Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+6.79% | 1.36B | |
+32.36% | 694B | |
+29.98% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.44% | 239B | |
+10.45% | 209B | |
-3.11% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- 000650 Stock
- News Renhe Pharmacy Co.,Ltd
- Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023.